Betaxolol hydrochloride (CAS No.: 63659-19-8)
Manus Aktteva Biopharma LLP, a global supplier of Betaxolol hydrochloride, 63659-19-8 offers for your requirements of RND / Development quantities or commercials, based on status of the product. We can also offer its intermediates with supportive technical package required for evaluation.
CAS number:
63659-19-8
Chemical Name:
1-(Isopropylamino)-3-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]propan-2-ol hydrochloride, Betaxolol hydrochloride (CAS No.: 63659-19-8)
Pharmacopeia:
USP, EP, BP
Certificate:
GMP, Factory GMP, GMP - SFDA, cGMP, Product GMP, EUGMP, WHO GMP, ISO Certified, USFDA
Application:
For R&D Purpose
Email To:
Your Email:
Your Name:
Note:
Processing....
Synonym
1-(Isopropylamino)-3-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]propan-2-ol hydrochloride, Betaxolol hydrochloride (CAS No.: 63659-19-8)
Specifications
Available on request
Packing
Export worthy packing
Material Safety Data Sheet
Available on request
| Product Name |
CAS No. |
|
| 4-Hydroxyphenylacetamide |
17194-82-0 |
View | Inquire |
| (Bromomethyl)cyclopropane |
7051-34-5 |
View | Inquire |
Description:
Betaxolol hydrochloride, CAS NO 63659-19-8, is a medicine which is used in ocular hypertension and open-angle glaucoma. Betaxolol should be used with caution in: People with asthma, People with diabetes, People with breathing problems & etc. Betaxolol also shows greater affininty for beta1 receptors than metoprolol. Betaxolol Hydrochloride Ophthalmic Solution contains betaxolol hydrochloride, a cardioselective beta-adrenergic receptor blocking agent, in a sterile isotonic solution. Manus Aktteva Biopharma LLP, a global supplier of Betaxolol hydrochloride offers for your requirements with supportive technical package required for evaluation.
- Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
- Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
- Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
- Manus Aktteva Biopharma LLP assumes no responsibility/liability in case of being imparted with goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual. Manus Aktteva makes no representations or warranties of any kind, express or implied, about the originality or reliability with respect to the intellectual property which includes patents in its products or services for any purpose.
- Manus Aktteva Biopharma LLP warns the sellers not to sell any goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual.
- Manus Aktteva Biopharma LLP warns the buyers not to use/procure any goods to achieve a product which might be knowingly causing an infringement of intellectual property in any manner whatsoever which includes patent rights of any individual.
Are you looking for Betaxolol hydrochloride (CAS No.: 63659-19-8) with documentation like PMDA - JAPAN, DMF - CANADA, DMF (CLOSED PART), MHRA - UK, DMF - KOREA, AIFA - ITALY, MEDSAFE - NEW ZEALAND, HEALTH CANADA, JDMF, JAPAN - AFM, DMF - CTD, DCGI, ICH, COPP, TDMF? Please
click here to send us sourcing request.
Betaxolol hydrochloride, 63659-19-8, USDMF, EDMF, CEP / COS, TGA - AUSTRALIA, DMF (OPEN PART), TDP, Written Confirmation, GMP, Factory GMP, GMP - SFDA, cGMP, Product GMP, EUGMP, WHO GMP, ISO Certified, USFDA, Price, Cost, Manufacturer, Exporter, Supplier, India, China, MSDS
Queries
Easy ways to get the answers you need.
+91 79 26463394
+91 79 26463395
